Fearon ER - Search Results

1

Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.

Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, Cho KR, Fearon ER. Hinoi T, et al. Among authors: fearon er. Cancer Res. 2007 Oct 15;67(20):9721-30. doi: 10.1158/0008-5472.CAN-07-2735. Cancer Res. 2007. PMID: 17942902

2

DCC: linking tumour suppressor genes and altered cell surface interactions in cancer?

Cho KR, Fearon ER. Cho KR, et al. Among authors: fearon er. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1055-60. doi: 10.1016/0959-8049(95)00128-6. Eur J Cancer. 1995. PMID: 7576991 Free article. Review.

3

DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?

Cho KR, Fearon ER. Cho KR, et al. Among authors: fearon er. Curr Opin Genet Dev. 1995 Feb;5(1):72-8. doi: 10.1016/s0959-437x(95)90056-x. Curr Opin Genet Dev. 1995. PMID: 7749329 Review.

4

The DCC gene product in cellular differentiation and colorectal tumorigenesis.

Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B. Hedrick L, et al. Among authors: fearon er. Genes Dev. 1994 May 15;8(10):1174-83. doi: 10.1101/gad.8.10.1174. Genes Dev. 1994. PMID: 7926722 Free article.

5

Transcriptional defects underlie loss of E-cadherin expression in breast cancer.

Ji X, Woodard AS, Rimm DL, Fearon ER. Ji X, et al. Among authors: fearon er. Cell Growth Differ. 1997 Jul;8(7):773-8. Cell Growth Differ. 1997. PMID: 9218871

6

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Among authors: fearon er. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

7

gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. Kolligs FT, et al. Among authors: fearon er. Genes Dev. 2000 Jun 1;14(11):1319-31. Genes Dev. 2000. PMID: 10837025 Free PMC article.

8

Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

Wu R, Connolly DC, Ren X, Fearon ER, Cho KR. Wu R, et al. Among authors: fearon er. Neoplasia. 1999 Oct;1(4):311-4. doi: 10.1038/sj.neo.7900042. Neoplasia. 1999. PMID: 10935485 Free PMC article.

9

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S. Giordano TJ, et al. Among authors: fearon er. Am J Pathol. 2001 Oct;159(4):1231-8. doi: 10.1016/S0002-9440(10)62509-6. Am J Pathol. 2001. PMID: 11583950 Free PMC article.

10

Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Wu R, Zhai Y, Fearon ER, Cho KR. Wu R, et al. Among authors: fearon er. Cancer Res. 2001 Nov 15;61(22):8247-55. Cancer Res. 2001. PMID: 11719457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters